A sixth province changes the map—and raises a hard question: can the response move as fast as the virus? A little context before today’s development: The DRC declared this Bundibugyo Ebola outbreak on May 15, but transmission had already been underway for months. Before this update, officials were tracking spread across five provinces and dozens of health zones, with more than 4,000 confirmed cases and more than 2,000 deaths reported. Contact follow-up, isolation capacity, insecurity, and delayed detection have remained the main constraints. This is Ebola Watch. Today, we’re looking at the outbreak’s spread—and whether promising treatment research can reach people before they ever get to care. Al Jazeera has the details. Six provinces now. We’d been tracking this DRC Bundibugyo outbreak across five provinces, and Africa CDC says the new Bas-Uele death is linked to travel from Haut-Uele. So the virus is moving along a real travel corridor. That link gives responders somewhere to focus follow-up: the people and routes connecting Haut-Uele to Bas-Uele. It documents geographic spread, rather than Ebola appearing in Bas-Uele independently. And that 82.7 percent contact-follow-up figure was across five provinces. Bas-Uele has made the map bigger before that metric can show how well the response is covering it. Al Jazeera reports 2,128 deaths among about 4,566 cases. Those are outbreak totals. The immediate concern is whether tracing teams, treatment access, and cross-border coordination can keep pace with this newly confirmed corridor. Here's World Health Organization:
At the same time, we're moving rapidly to generate evidence on treatments. The WHO-sponsored PARTNERS trial has now reached the milestone of hundred patients. This trial demonstrates that even in the midst of a challenging outbreak, it's possible to mobilize research rapidly and responsibly.
After that sixth-province report, WHO’s update puts a hard number on the response gap: $264 million has been disbursed toward a $518 million plan. That leaves roughly $254 million still needing to reach the field, where security and access are already constraining the work. A response that’s only half-funded can’t operate at full strength. If contact teams, transport, or protective supplies can’t safely reach affected areas, that funding shortfall means missed follow-up. WHO says its PARTNERS treatment trial has enrolled 100 patients. That shows a trial can be built during an outbreak, but it doesn’t yet tell us which treatment works best or change care for a patient overnight. And WHO wants to get the vaccine into a Phase 3 trial as soon as possible because its effectiveness against Bundibugyo disease in people is still unknown. One hundred trial participants is encouraging, but with the outbreak moving, it’s also a reminder that the evidence race is still underway. If Ebola Watch helps you stay informed, please subscribe and leave us a review wherever you’re listening. Your feedback helps other people find the show, and we’re grateful you’re here.
Links to every story are in the show notes, so take a look at the ones you’d like to explore further. Thanks for listening, and have a good Friday. That’s Ebola Watch for today. This is a Lantern Podcast.